4 common side effects of ruxolitinib/ruxolitinib cream

Ruxolitinib is a targeted therapy drug that is a JAK inhibitor and is mainly used to treat some immune-related diseases, such as atopic dermatitis (eczema). The drug modulates the immune response and reduces the inflammatory response by inhibiting the Janus kinase (JAK) pathway, thereby alleviating related symptoms. Although ruxolitinib cream is highly effective in treating these skin conditions, it may also cause some side effects. The following are common side effects when using ruxolitinib cream.

First, local skin reactions are one of the most common side effects when using ruxolitinib cream. Patients may experience mild skin irritation, itching, or dryness where the ointment is applied. These reactions are usually temporary and will gradually lessen or disappear with continued use of the medication. However, for sensitive skin, less frequent use or dosage adjustment may be necessary.

Second, increased risk of infection is also a side effect that needs to be noted when using ruxolitinib cream. The mechanism of action of JAK inhibitors is to suppress the immune response. Although this helps reduce inflammation, it may also reduce the body's ability to fight infection. Some patients who use ruxolitinib cream may be more susceptible to infections by bacteria, fungi and other microorganisms on the skin or other parts of the body. Therefore, skin condition should be checked regularly and precautions should be taken while using this medication.

Third, pigmentation changes are also a possible side effect, especially in patients who use ruxolitinib cream for a long time. Some patients may experience pigmentation or skin discoloration where the ointment is applied. This condition is usually temporary and does not affect the overall health of the skin, but it can cause some psychological stress for some patients who are sensitive to appearance.

Reference: https://www.opzelura.com/